Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
861 to 880 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| U54CA209978 | Combating Subclonal Evolution of Resistant Cancer Phenotypes | 1 | 2021 |
| U54CA209992 | Analysis of the regulatory networks regulating district stem cell-like states in aggressive cancers | 1 | 2021 |
| UH3TR002158 | A Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing | 1 | 2021 |
| ZIAAR041196 | Laboratory of Oral Connective Tissue Biology | 1 | 2021 |
| ZIABC011124 | Oncogenic Met Signaling in Urologic Malignancies | 1 | 2021 |
| ZIAES021164 | Environmentally Induced Alterations In Neuron And Glia Development and Aging | 1 | 2021 |
| ZIAES103286 | Characterization of the molecular mechanisms of LC3-associated phagocytosis and its role in disease pathogenesis | 1 | 2021 |
| ZIAES103349 | Molecular Pathogenesis of Rodent Neoplasia | 1 | 2021 |
| ZICES103316 | Toxicological Assessments for the Division of the National Toxicology Program | 1 | 2021 |
| ZICES103319 | Toxicologic Pathology Evaluations for the Division of the National Toxicology Program | 1 | 2021 |
| R01CA198291 | Preclinical Testing of a Novel Therapy Targeting AXL in Advanced Kidney Cancer | 6 | 2020 |
| K12HD068372 | Training in Basic and Translational Child Health Research | 5 | 2020 |
| P50DE026787 | Head and Neck Cancer SPORE at the University of Wisconsin | 3 | 2020 |
| R00CA207744 | Single Cell In Vivo Imaging Technology to Analyze Taxane Nano Formulations in Breast Cancer | 3 | 2020 |
| R01NS052632 | Neuroprotection and repair during West Nile Virus Encephalitis | 3 | 2020 |
| U54CA210181 | Center for Immunotherapeutic Transport Oncophysics | 3 | 2020 |
| P01CA128814 | ER Stress and Mitochondrial Biogenesis in Melanoma | 2 | 2020 |
| R01AI072690 | Remodeling of Lymph Node-Derived Cytokine Responses at the Infected Tissue Site | 2 | 2020 |
| R01CA197796 | Mechanisms of EXO1 regulation in response to radiation-induced DNA damage | 2 | 2020 |
| R01DK108195 | Interaction of protein-targeted therapeutics and ciliary dynamics | 2 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=44